Global Respiratory Care Devices Market Expected to Reach USD 43.5 Billion by 2033 - IMARC Group

Global Respiratory Care Devices Market Statistics, Outlook and Regional Analysis 2025-2033

The global respiratory care devices market size was valued at USD 23.5 Billion in 2024, and it is expected to reach USD 43.5 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% from 2025 to 2033.

At present, rising cases of chronic respiratory diseases, such as asthma and sleep apnea, attributed to factors like smoking, pollution, and aging populations, are driving the demand for advanced respiratory care solutions. Moreover, the increasing number of public health campaigns and initiatives by governments and organizations to spread awareness about early diagnosis and treatment of respiratory diseases are contributing to the market growth. Apart from this, the introduction of advanced respiratory care devices with features like improved algorithms, precise detection capabilities, and customizable therapy options is strengthening the market growth. These innovations enhance patient comfort, improve treatment accuracy, and meet the growing demand for effective solutions for sleep-related breathing disorders. In line with this, in 2024, Oxymed launched the SleepEasy Auto CPAP device in India, featuring advanced FlowSens algorithms for superior comfort and CSA detection for precise sleep apnea management. The device offers customizable therapy modes, adjustable pressure, and ramp settings, providing an affordable yet premium solution for sleep-related breathing disorders.

Furthermore, the rising number of surgeries worldwide, particularly those requiring anesthesia, is catalyzing the demand for respiratory monitoring and support devices to ensure patient safety during and post-procedure. In addition, the increasing awareness about respiratory conditions among infants, such as neonatal respiratory distress syndrome, is driving the demand for specialized pediatric respiratory devices. Besides this, strategic partnerships between companies are contributing to the development and availability of advanced respiratory care solutions. Collaborative efforts foster innovation, enabling the creation of non-invasive and versatile devices that cater to both hospital and home settings. For instance, in 2024, AGAPE ATP Corporation and FORMEDIC Technologies announced their collaboration to launch LEGA, an electronic chest percussion device for managing respiratory conditions like COPD and bronchiectasis. Designed for hospital and home use, LEGA enhances airway clearance and secretion management with non-invasive technology. The partnership aims to expand worldwide access to advanced respiratory care solutions.

Global Respiratory Care Devices Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of well-established healthcare infrastructure and high prevalence of respiratory conditions among the masses.

North America Respiratory Care Devices Market Trends:

North America dominates the market, supported by advanced healthcare infrastructure and rising investment in innovative medical technologies. The region benefits from high awareness about respiratory health, increasing prevalence of chronic respiratory diseases, and the availability of cutting-edge therapeutic and diagnostic devices. Continuous advancements in non-invasive technologies and telemedicine integration further enhance the dominant position of the region in the market. In 2024, Baxter launched The Vest Advanced Pulmonary Experience (APX) System, a next-generation airway clearance device designed for patients with chronic lung conditions like cystic fibrosis and bronchiectasis. Using High Frequency Chest Wall Oscillation technology, it enhances mucus clearance with added comfort, intuitive touch controls, and customizable garment designs. The system received FDA clearance and supports daily therapy with improved portability and user-friendly features.

Asia-Pacific Respiratory Care Devices Market Trends:

Asia Pacific is experiencing growth in the respiratory care devices market because of the expanding healthcare access and rising awareness about respiratory conditions. The region benefits from increasing healthcare investments and a growing focus on improving patient outcomes through advanced medical devices. The rising need for affordable healthcare solutions in the region is resulting in the adoption of both hospital and home-based respiratory devices.

Europe Respiratory Care Devices Market Trends:

Europe holds a notable market share, characterized by strong healthcare systems and an emphasis on early diagnosis and management of chronic diseases. Innovations in non-invasive therapeutic solutions and rising adoption of portable devices are supporting the market growth. Additionally, government initiatives to enhance healthcare services are offering a favorable outlook.

Latin America Respiratory Care Devices Market Trends:

Latin America shows promising potential in the respiratory care devices market because of the growing healthcare investments and improving infrastructure. Increasing awareness about respiratory diseases and advancements in medical technologies are encouraging the adoption of modern therapeutic and diagnostic devices. The region is gradually embracing home-based care solutions, enhancing market opportunities.

Middle East and Africa Respiratory Care Devices Market Trends:

The Middle East and Africa region is witnessing growth in the respiratory care devices market because of the increasing healthcare investments and a focus on improving medical infrastructure. Rising awareness about the importance of respiratory health and access to innovative therapeutic solutions are contributing to the market growth. Efforts to modernize healthcare systems are further accelerating the adoption of advanced respiratory devices in this region.

Top Companies Leading in the Respiratory Care Devices Industry

Some of the leading respiratory care devices market companies include Philips Healthcare, ResMed, Chart Industries Inc., Hamilton Medical, Medtronic, Masimo, Drägerwerk, Invacare Corporation, Allied Healthcare Products Inc, 3B Medical Inc., Air Liquide, Fisher & Paykel Healthcare, GE Healthcare, Vyaire Medical Inc., and Rotech Healthcare Inc., among many others. In 2024, ResMed launched the AirCurve 11, a bi-level respiratory support device offering an alternative to CPAP machines for sleep apnea treatment. The device adapts to breathing patterns of users employing advanced algorithms and integrates with digital platforms for remote monitoring and patient engagement.

Global Respiratory Care Devices Market Segmentation Coverage

• On the basis of the product, the market has been categorized into therapeutic devices (positive airway pressure (PAP) devices, ventilators, nebulizers, humidifiers, inhalers and others), monitoring devices (pulse oximeters, gas analyzers and others), diagnostic devices (spirometers, polysomnography devices, peak flow meters, and others), and consumables and accessories (masks, disposable resuscitators, breathing circuits, tracheostomy tubes, nasal cannulas and others), wherein therapeutic devices (positive airway pressure (PAP) devices, ventilators, nebulizers, humidifiers, inhalers and others) represent the leading segment. Therapeutic devices dominate the market because of their critical role in managing and treating respiratory disorders, such as asthma and sleep apnea. Positive airway pressure (PAP) devices and ventilators are at the forefront of this segment, supported by their widespread use in both home care and hospital settings. The rising prevalence of respiratory conditions, coupled with advancements in portable and user-friendly therapeutic devices, are supporting the market growth.
• Based on the indication, the market is classified into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious disease, and others, amongst which chronic obstructive pulmonary disease (COPD) dominates the market. Chronic obstructive pulmonary disease (COPD) represents the largest segment driven by the high prevalence of the condition and the increasing need for effective management solutions. Rising rates of smoking, air pollution, and aging populations contribute to the growing incidence of COPD. Devices, such as ventilators, nebulizers, and PAP systems are widely utilized for treating and managing COPD symptoms, improving the quality of life of patients.
• On the basis of the end-user, the market has been divided into hospitals, home care settings, ambulatory care centers, and others. Among these, hospitals account for the majority of the market share. Hospitals lead the market owing to their extensive infrastructure and ability to provide advanced care for critical respiratory conditions. These facilities are equipped with cutting-edge devices, including ventilators and monitoring systems, to address acute respiratory emergencies effectively. Additionally, hospitals benefit from skilled professionals who ensure accurate device utilization, enhancing patient outcomes.

Browse IMARC Related Reports on Respiratory Care Devices Market:

• Japan Respiratory Care Devices Market Report